In order to ascertain whether galectin-1 may be implicated in the progression of MASLD, we analyzed the relationship between galectin-1 and MASLD-related metabolic indicators. The gene discussed is LGALS1; the disease is metabolic dysfunction-associated steatotic liver disease.